Worsening of early DME after cataract surgery. The DICAT II Study report #2

Marco R Pastore,Alex Lucia Vinciguerra,Giulia Dalla Mura,Abdallah El Jabali,Daniele Tognetto,Giacomo Panozzo,Marco R. Pastore
DOI: https://doi.org/10.1177/11206721241245743
2024-04-07
European Journal of Ophthalmology
Abstract:European Journal of Ophthalmology, Ahead of Print. PurposeTo analyse the long anatomical and functional outcome of a subgroup of the DICAT II study cohort, consisting of 26 patients undergoing cataract surgery and withdrawn from the study for a clinically significant worsening of early diabetic macular edema (DME).MaterialsPatients who underwent cataract surgery and withdrawn from the DICAT II study for a clinically significant worsening of early DME with at least 12 months follow–up after the dropout. The study population was divided into two groups according to the clinical evaluation at one-year follow-up: ongoing treatment patients for DME (Treatment group, TG) and patients no longer treated (Non Treatment group, NTG).ResultsCentral foveal thickness (CFT) at baseline and dropout time were higher in TG than in the NTG, with a statistically significant difference (p < 0.05). In addition, TG patients reported a higher levels of glycated hemoglobin at time baseline compared to NTG patients (7.81 ± 1.15 vs 7.02 ± 0.56; p = 0.048). The linear regression analysis demonstrated a statistically significant relationship between the visual acuity and the ongoing treatment group at one-year follow-up (p = 0.042).ConclusionThe study provides parameters to be considered when assessing the risk of developing persistent DME after cataract surgery in diabetic patients. In particular, CFT at baseline and dropout time have been reported to be an effective and predictable OCT biomarkers when evaluating DME progression. During the evaluation of the systemic disease, similar results were found for the glycated hemoglobin at baseline.
ophthalmology
What problem does this paper attempt to address?